These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2206 related items for PubMed ID: 31037488
1. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B. Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488 [Abstract] [Full Text] [Related]
2. Optical coherence tomography angiography versus fluorescein angiography in diagnosing choroidal neovascularization in chronic central serous chorioretinopathy. Bansal R, Dogra M, Mulkutkar S, Katoch D, Singh R, Gupta V, Dogra MR, Gupta A. Indian J Ophthalmol; 2019 Jul; 67(7):1095-1100. PubMed ID: 31238419 [Abstract] [Full Text] [Related]
5. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C. Ophthalmologica; 2017 Jul; 237(3):167-172. PubMed ID: 28171871 [Abstract] [Full Text] [Related]
6. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Azar G, Wolff B, Mauget-Faÿsse M, Rispoli M, Savastano MC, Lumbroso B. Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633 [Abstract] [Full Text] [Related]
7. Three-Year Follow-Up Detecting Choroidal Neovascularization with Swept Source Optical Coherence Tomography Angiography (SS-OCTA) after Successful Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Esteban-Floría O, Pérez-Rivasés G, Honrubia-Grijalbo A, Bartolomé-Sesé I, Díaz-Barreda MD, Boned-Murillo A, Cisneros-Arias P, Mateo-Gabás J, Ascaso-Puyelo FJ. Diagnostics (Basel); 2023 Aug 29; 13(17):. PubMed ID: 37685332 [Abstract] [Full Text] [Related]
8. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy. Hanumunthadu D, Matet A, Rasheed MA, Goud A, Vuppurabina KK, Chhablani J. Indian J Ophthalmol; 2019 Nov 29; 67(11):1850-1854. PubMed ID: 31638047 [Abstract] [Full Text] [Related]
10. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. Hamzah F, Shinojima A, Mori R, Yuzawa M. BMC Ophthalmol; 2014 Nov 25; 14():145. PubMed ID: 25421855 [Abstract] [Full Text] [Related]
13. The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment. Azzolini C, Cattaneo J, Premoli L, Metrangolo C, Chiaravalli M, Donati S. Int Ophthalmol; 2021 Jun 25; 41(6):2109-2116. PubMed ID: 33748901 [Abstract] [Full Text] [Related]
18. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Int Ophthalmol; 2017 Jun 25; 37(3):483-489. PubMed ID: 27392913 [Abstract] [Full Text] [Related]
19. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Baek J, Lee JH, Jung BJ, Kook L, Lee WK. Graefes Arch Clin Exp Ophthalmol; 2018 Dec 25; 256(12):2309-2317. PubMed ID: 30259090 [Abstract] [Full Text] [Related]